Skip to content
AwardedSpainGoods

Adquisición de vacunas frente al Virus del Papiloma Humano (VPH) nonavalente para la captación de vacunación de cohortes pendientes.

Published
Published 17 June 2026

Overview

The Government of La Rioja procured 10,000 doses of nonavalent human papillomavirus (HPV) vaccine containing L1 protein from genotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58 for vaccination of pending cohorts. The contract was awarded to Merck Sharp & Dohme de España, S.A. on 5 June 2026 for €450,000.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
17 June 2026
Classification (CPV)
Vaccines

Award outcome

Awarded value
€450,000
Award date
5 June 2026
Contract period
— → 31 December 2026
Winner
  • MERCK SHARP & DOHME DE ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 June 2026

Contracting authority

  • Gobierno de La Rioja

    Procuring entity

    Logroño, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Adquisición de vacunas frente al Virus del Papiloma Humano (VPH) nonavalente para la captación de vacunación de cohortes pendientes. — won by MERCK SHARP & DOHME DE ESPAÑA, S.A. — Skim